Incidence, Impact and Mechanisms of Perioperative Right VEntricular Dysfunction (IMPRoVE)
NCT ID: NCT05827315
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
175 participants
OBSERVATIONAL
2023-04-30
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study
NCT03155373
Construction of a Prediction Model for MACCE in Elderly Patients After Elective Non-cardiac Surgery
NCT06391632
Prospective Evaluation of Asians With CRT for Heart Failure
NCT02814942
Haemodynamics of Mitral Regurgitation Reduction
NCT05403840
Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation
NCT03154034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our research group has specialist knowledge about the right-hand side of the heart (right-heart) - the side that pumps blood through the lungs - which is less commonly considered or studied around the time of surgery. We have shown in previous studies using magnetic resonance imaging (MRI) scans (specialised whole-body scans which use a magnet rather than X-rays), evidence of right-heart function deteriorating after surgery. We want to test the idea that some of the blood marker evidence of heart injury reflects injury to the right-heart and more importantly that we can protect the right-heart around the time of surgery, reducing injury and improving patient outcomes.
We will examine these questions in the following ways:
1. With patients' permission, we will perform detailed ultrasound scans of the heart (echocardiography), and blood measurement of injury markers in 175 patients undergoing different types of major surgery. This will allow us to assess how common heart injury is (visible on scans of both sides of the heart), whether it makes any difference to a patient's outcome and whether it explains the changes seen in blood markers.
2. We will ask 50 of these patients to undergo MRI scans of the heart pre- and post-operatively to allow us to identify evidence of injury resulting from heart inflammation around the time of surgery. Inflammation is common following surgery and occurs throughout a patient's body - we believe heart inflammation may be responsible for postoperative heart injury.
3. In 10 of these patients, we will seek to obtain blood samples from vessels flowing into the heart (easily obtained from a simple blood sample) and from veins flowing out of the heart, obtained by passing a fine tube into the heart via blood vessels in a patient's neck under X-ray guidance. This will allow us to examine what happens to immune cells as they pass through the heart (i.e., are they activated by heart inflammation?) and better understand the meaning of the changes seen on MRI scans.
This study will give us a better understanding of which patients are likely to suffer heart injury around the time of surgery and how this injury occurs. With this knowledge, future patients could receive personalised treatment plans aimed at preventing injury and improving outcomes. We are not testing any new treatments in this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thoracic surgery cohort
35 patients undergoing thoracic surgery with lung resection and one lung ventilation under primarily general anaesthesia.
Echocardiography
Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.
T1 Cardiovascular Magnetic Resonance
T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.
Right heart catheterisation and coronary sinus blood sampling
10 patients from the thoracic surgical group will undergo right heart catheterisation and coronary sinus blood sampling.
Upper gastrointestinal surgery cohort
35 patients undergoing upper gastrointestinal surgery with one lung ventilation under primarily general anaesthesia.
Echocardiography
Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.
T1 Cardiovascular Magnetic Resonance
T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.
Colorectal surgery cohort
35 patients undergoing elective colorectal surgery under primarily general anaesthesia.
Echocardiography
Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.
T1 Cardiovascular Magnetic Resonance
T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.
Vascular surgery cohort
35 patients undergoing elective open abdominal aortic surgery under primarily general anaesthesia.
Echocardiography
Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.
T1 Cardiovascular Magnetic Resonance
T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.
Orthopaedic surgery cohort
35 patients undergoing elective primary hip or knee arthroplasty under spinal anaesthesia +/- sedation.
Echocardiography
Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.
T1 Cardiovascular Magnetic Resonance
T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiography
Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.
T1 Cardiovascular Magnetic Resonance
T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.
Right heart catheterisation and coronary sinus blood sampling
10 patients from the thoracic surgical group will undergo right heart catheterisation and coronary sinus blood sampling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age \>18 years
3. Planned elective primary hip or knee joint replacement under spinal anaesthesia, major colorectal, major vascular surgery or surgery requiring one lung ventilation with or without lung resection
Exclusion Criteria
2. On-going participation in any investigational research which could undermine the scientific basis of the study
3. Previous major surgery within three months prior to recruitment
4. Previous participation in the IMPRoVE study at any time
5. Inadequate comprehension of English resulting in inability to comply with instructions while undergoing investigations required for main study and sub-studies.
1. Atrial fibrillation at baseline
2. Contraindication to cardiac magnetic resonance imaging (metal work in body etc)
3. Contraindication to IV Gadolinium: acute or chronic renal failure, allergy to contrast
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Glasgow
OTHER
NHS Greater Glasgow and Clyde
OTHER
Royal London Hospital
UNKNOWN
NHS National Waiting Times Centre Board
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Ben Shelley
Honorary Professor/Consultant in Cardiothoracic Anaesthesia and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ben Shelley
Role: PRINCIPAL_INVESTIGATOR
National Waiting Times Centre Board
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Golden Jubilee National Hospital
Clydebank, , United Kingdom
Glasgow Royal Infirmary
Glasgow, , United Kingdom
Queen Elizabeth University Hospital
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ben Shelley
Role: primary
Rachel Kearns
Role: primary
Malcolm Watson
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Keast T, McErlane J, Kearns R, McKinlay S, Raju I, Watson M, Robertson KE, Berry C, Greenlaw N, Ackland G, McCall P, Shelley B. Study protocol for IMPRoVE: a multicentre prospective observational cohort study of the incidence, impact and mechanisms of perioperative right ventricular dysfunction in non-cardiac surgery. BMJ Open. 2023 Sep 6;13(9):e074687. doi: 10.1136/bmjopen-2023-074687.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22/ANAES/06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.